| ²é¿´: 1394 | »Ø¸´: 12 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
batilgoal½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
ҽѧÂÛÎÄÓ¢ÎÄժҪд×÷¼¼ÇÉ
|
||
|
ҽѧÂÛÎÄ£¨medical papers£©µÄ¶¨Òå ҽѧÂÛÎÄÊǶÔÕûÀíºÍ·¢±íҽѧÑо¿³É¹ûµÄÒ»ÖÖÌØÊâÎı¾µÄ×ܳƣ¬¾ÍÆäÄÚÈݺÍÎÄÌåÌØµã¶øÑÔ¿Æ·ÖΪÒÔϼ¸ÖÖ£º 1£®Ò½Ñ§¿ÆÑÐÂÛÎÄ£¨scientific papers£© 2£®µ÷²é±¨¸æ£¨survey£© 3£®×ÛÊö£¨review£© 4£®Ñ§Î»ÂÛÎÄ£¨theses£© 5£®Ò½Ñ§¿ÆÑÐÂÛÎÄ£¨scientific papers£© ҽѧ¿ÆÑÐÂÛÎ͍Òå ¹ú¼ÊÉúÎïѧ±à¼Î¯Ô±»á¶Ôҽѧ¿ÆÑÐÂÛÎĵ͍ÒåΪ£º±ØÐëÊÇÊ״ι«²¼µÄÓ¦Ìṩ×ã¹»µÄ×ÊÁÏ£¬Ê¹Í¬ÐÐÃÇÄܹ»½øÐУº¢ÙÆÀ¼ÛËù¹Û²ìµ½µÄ½á¹û£»¢ÚÆÀ¼ÛÆäÍÆÀí¹ý³Ì£»¢ÛÖØ¸´ÊµÑé¡£·ÖΪÒÔÏÂÁ½ÖÖ£º¢ÙÁÙ´²Ñо¿(clinical study)£»¢Ú»ù´¡Ñо¿»òʵÑéÑо¿£¨experimental study) ҽѧ¿ÆÑÐÂÛÎĵĸñʽ ҽѧ¿ÆÑÐÂÛÎıØÐë¾ß±¸ÒÔϼ¸¸ö²¿·Ö£º £¨1£©±êÌ⣨title£© £¨2£©ÕªÒª£¨abstract£© £¨3£©ÒýÑÔ£¨introduction£© £¨4£©²ÄÁϺͷ½·¨£¨materials and methods£© £¨5£©½á¹û£¨results£© £¨6£©ÌÖÂÛ£¨discussion£© £¨7£©ÖÂл£¨acknowledgement£© £¨8£©²Î¿¼ÎÄÏ×£¨references£© Ò»¡¢±êÌâ £¨Ò»£©ÒªÇó 1£®¼òÃ÷¶óÒª£¨short and concise£© £¨1£©¾¡Á¿¿ØÖÆÔÚÒ»ÐУ¬µ«²»ÊÇÒ»¸ö¾ä×Ó £¨2£©²»³¬¹ý25¸öµ¥´Ê»ò120-140¸ö×Öĸ £¨3£©³ýDNA¡¢RNA¡¢CTµÈ²»ÓÃËõд 2£®ÐÅÏ¢·á¸»(informative) 3£®±ãÓÚË÷Òý£¨indexing£© 4£®½Ï³¤±êÌâ¿É²ÉÓø±±êÌâ £¨¶þ£©±êÌâд×÷Öг£ÓôÊ×éºÍ±í´ï·½Ê½ 1£®Óᣨ·½·¨£¯ÊֶΣ©¶Ô¡½øÐÐÑо¿£¯·ÖÎö£¯¹Û²ì£¯ÆÀ¼Û£º Study(analysis/observation/evaluation/assessment) of (on) ¡ (by) using ·½·¨/with¹¤¾ß£© 2£®A¶ÔBµÄ×÷Óà Effort of A on B Protective effect of omeprazole on endothelin-induced gastric mucosal injury 3£®AÓëBµÄ¹ØÏµ Correlation (relation/relationship) between A and B Correlation of A with B and C ³£ÓÃÐÞÊδʣºpositively/negatively/significantly/insignificantly ±êÌâд×÷Öг£ÓôÊ×éºÍ±í´ï·½Ê½ 4£®ÓáÖÎÁÆ¡ Use of ¡in the treatment of ¡(²¡£©in ¡£¨ÉúÎ Use of omeprazole in the treatment of gastric ulcer in the elderly 5£®AÊÇB A as B ¶þ¡¢ÖøÂ¼²¿·ÖÊéд £¨Ò»£©ÐÕÃû ±ê׼ʽ£ºWANG Luowei£¬HUANG Yingfeng£¬GUO Xiao¡¯an £¨¶þ£© µØÖ· 800 Xiang Yin Road, Shanghai 200433, P.R.China £¨Èý£©×ÊÖú A project funded by the National ¡°863¡± Program Èý¡¢ÕªÒªµÄ·ÖÀàÓë¸ñʽ ÕªÒªÊÇ×÷ÕßÒª¸ø¶ÁÕߵľ«»ª£¬·ÖÁ½´óÀࣺ £¨Ò»£©Ö¸Ê¾ÐÔÕªÒª £¨¶þ£©×ÊÁÏÐÔÕªÒª 1£®·Ç½á¹¹Ê½ÕªÒª ȱµã£º¶ÎÂä²»Ã÷£¬¸ø±à¼¡¢Éó¸å¡¢ÔĶÁºÍ¼ÆËã»ú´¦Àí´øÀ´Öî¶à²»±ã 2£®È«½á¹¹Ê½ÕªÒª£¨8ÒªËØÕªÒª£© £¨1£©Ä¿µÄ £¨2£©Éè¼Æ £¨3£©µØµã £¨4£©¶ÔÏó £¨5£©´¦Àí £¨6£©Ö÷Òª²â¶¨ÏîÄ¿ £¨7£©½á¹û £¨8£©½áÂÛ È«½á¹¹Ê½ÕªÒªµÄÓŵ㠣¨1£©¹Ûµã¸üÃ÷È· £¨2£©ÐÅÏ¢Á¿¸ü´ó £¨3£©²î´í¸üÉÙ £¨4£©·ûºÏ¼ÆËã»úÊý¾Ý¿â½¨Á¢ºÍʹÓõÄÒªÇó È«½á¹¹Ê½ÕªÒªµÄȱµã£º·³Ëö¡¢Öظ´¡¢Æª·ù¹ý³¤ 3£®°ë½á¹¹Ê½ÕªÒª£¨ËÄÒªËØÕªÒª£© £¨1£©Ä¿µÄ£¨objective/purpose/aim£© £¨2£©·½·¨£¨methods£© £¨3£©½á¹û£¨results£© £¨4£©½áÂÛ£¨conclusion£© Ä¿µÄ ÊÇÖ÷Ì⣬ÊÇ×÷ÕßÏàÒª½éÉܵĹؼüÎÊÌâ Ò»¡¢Ä¿µÄ¸ñʽ £¨Ò»£©µ¥±íÄ¿µÄ £¨¶þ£©±³¾°£«Ä¿µÄ ¶þ¡¢Ä¿µÄ³£ÓÃʱ̬ £¨Ò»£©±³¾°£ºÏÖÔÚʱ£¨Ò»°ãÏÖÔÚʱ¡¢Íê³ÉʱºÍ½øÐÐʱ£© £¨¶þ£©Ä¿µÄ£ºÒ»°ãÏÖÔÚʱ£¯ÏÖÔÚÍê³Éʱ£¬»òÒ»°ã¹ýȥʱ ¾ÙÀý£º £¨1£©To evaluate the effects on 24-hour intragastric pH levels of infusions with omeprazole and H2 receptor antagonists in bleeding duodenal ulcer patients. £¨2£©The role of omeprazole in triple therapy and the impact of Helicobacter pylori resistance on treatment outcome are not established. This study investigated the role of omeprazole and influence of primary H. pylori resistance on eradication and development of secondary resistance. Èý¡¢½éÉÜÄ¿µÄ³£ÓþäÐÍ Ö÷ÒªÓö¯´Ê²»¶¨Ê½to±í´ï 1£®Ö±½ÓÓÃto do¶ÌÓï±í´ï ¾ÙÀý£ºTo determine if use of omeprazole protects against the gastric mucosal injury 2£®The purpose/aim/objective/goal(of present study is)was to ¾ÙÀý£ºThe aim of this study was to determine the protective function of omeprazole on gastric mucosal injury3£®The present study is /was designed/devised/intended to ¾ÙÀý£ºThe present study was designed to establish whether there might be a genetic predisposition to an altered pattern of anti-inflammatory cytokine produced in patients with irritable bowel syndrome 4£®This study was performed/conducted/carried out/undertaken to ¾ÙÀý£ºAn experimental study was conducted using a canine mode to elucidate ¡5£®We aimed/sought to/attempted to ¾ÙÀý£ºWe sought to assess whether there is an increased risk of tuberculosis among individuals who work in certain industries occupations. ËÄ¡¢½éÉÜÄ¿µÄ³£Óö¯´Ê 1£®Ñо¿£ºstudy, investigate, examine, observe, explore ¾ÙÀý£ºOur objective in this report is to examine the clinical feature, pathology and treatment for patients with pancreatic cancer. 2£®ÆÀ¼Û£ºevaluate, validate ¾ÙÀý£ºTo evaluate sonography as a tool for initial diagnosis in emergency room patients with abdominal trauma. 3£®È·¶¨£ºdetermine, decide, confirm, support, define, characterize 4£®Ö¤Êµ£ºprove, demonstrate, document, test, support, testify, verify 5£®²ûÃ÷¡¢¸ãÇ壺explain, elucidate, clarify, illustrate, delineate, find out, contribute to the knowledge of 6£®½éÉÜ£ºdescribe, present, report 7£®½¨Á¢£ºestablish, develop, set out 8£®Ñ°ÕÒ£ºsearch for, look for, seek, find 9£®Ê¶±ð¡¢Çø·Ö£ºidentify, differentiate, discriminate 10£®ÓÅÑ¡£ºoptimize 11£®±È½Ï£ºcompare 12£®»Ø¹Ë£ºreview 13£®Ïà¹Ø£ºcorrelate A with B ·½·¨²¿·Ö £¨1£©Ñо¿Éè¼Æ £¨2£©Ñо¿¶ÔÏóµÄÌØÐÔ £¨3£©¸ÉÔ¤»ò´¦Àí·½·¨ £¨4£©²â¶¨»ò¹Û²ì·½·¨ Ò»¡¢ Ñо¿¶ÔÏóµÄÑ¡Ôñ¡¢À´Ô´¼°±ê×¼ 1£®ÄÉÈëÑо¿£ºwere entered into/enrolled in/selected (randomly) ¾ÙÀý£ºA total of 169 patients were included in the study, 83 of whom received¡¡ 2£®Åųý»òÍ˳öÑо¿£ºwere excluded from participation£¬withdrew from the study due to/because to ¾ÙÀý£º¡¡Patients with significant aortic valvular diseases were excluded. ¶þ¡¢ Ñо¿¶ÔÏóµÄ·Ö×é 1£®¡¡were divided into/classified/grouped into 2£®¡¡were divided randomly/randomized into 3£®¡¡ were divided equally into ¾ÙÀý£ºPatients were divided into three groups: Group 1¡¡ Patients (n = 539) with a history of duodenal ulcer and a positive H. pylori screening test result were randomized into 4 groups. OAC group received 20 mg omeprazole, ¡¡ Èý¡¢ ÄêÁä 1£®Ä³Ò»ÄêÁä ¾ÙÀý£ºA 50-year-old patient. Patients (age 26¡À3 years). 2£®ÔÚijÄêÁ䷶ΧÄÚ¼°Æ½¾ùÄêÁä ¾ÙÀý£ºPatients range in age from ¡to¡, with a mean of (50 years) 3£®ÔÚijһÄêÁäÒÔÉÏ»òÒÔÏ ¾ÙÀý£ºPatients more than 50 years. Patients under/less than 50 years. ËÄ¡¢ ÐÔ±ð¡¢Ê±¼ä 1£®ÐÔ±ð twelve patients (7 male and 5 female ) The male-to-female ratio was 1:4 2£®Ê±¼ä Body weight was measured weekly, and liver biopsy was obtained at 4, 8 and 12 weeks. ¡¡ Îå¡¢ Õï¶ÏÓëÖÎÁÆ 1£®Õï¶Ï be diagnosed as having ¡ be diagnosed as ¡by ¡/with ¡®be suspected as ¡ 2£®ÖÎÁÆ be treated with¡(alone or in combination with ¡) be treated on outpatient/inpatient basis ¾ÙÀý£º £¨1£©Patients (n = 539) with a history of duodenal ulcer and a positive H. pylori screening test result were randomized into 4 groups. OAC group received 20 mg omeprazole,¡ £¨2£©50 patients with active bleeding duodenal ulcer were randomly assigned to receive one of the four treatment regimens. ¡ ½á¹û²¿·Ö 1£®ÊÇÎÄÕ½áÂ۵ĸù¾Ý 2£®Ó¦¼ÇÂ¼ÕæÊµµÄ¿ÆÑÐÊý¾Ý 3£®³ýָʾÐÔ˵Ã÷Í⣬һ°ãÓùýȥʱ±íʾ Ò»¡¢ ³£ÓþäÐÍ 1£®½á¹û±íÃ÷£ºThe results showed / demonstrated / revealed / documented / indicated/suggested¡that¡®It was found that¡ ¾ÙÀý£ºThe results showed that high thigh cuff Doppler technique was 79 percent sensitive, 56 percent specific and 63 percent accurate. 2£®Óë¡ÓйأºA was related / correlated /associated with B. There was a relationship /correlation between A and B. There was a relation of A with B and C ¾ÙÀý£ºInsulin sensitivity index was negatively with blood velocity (r=0.530, P<0.05), body mass index (r=o.563, P<0.01) and baseline insulinemia (r=0.489, P<0.05) 3£®Ôö¼Ó»ò¼õÉÙ £¨1£©±íʾÊýÖµÔö¼ÓµÄ¶¯´Ê£ºincrease, rise, elevate £¨2£©±íʾÊýÖµÔö¼ÓµÄÃû´Ê£ºincrease, increment, elevation £¨3£©±íʾÊýÖµ¼õÉٵ͝´Ê£ºdecrease, reduce, fall, drop, decline, lower £¨4£©±íʾÊýÖµ¼õÉÙµÄÃû´Ê£ºdecrease, decrement, reduction, fall, drop, decline, lowering £¨5£©´Ó¡Ôö¼Óµ½¡£¬Æ½¾ùÔö¼Ó¡£ºincrease from ¡to ¡, with a mean/average (increase) of ¡ £¨6£©´Ó¡Ôö¼Óµ½¡£¬×ܵÄÔö¼Ó¡£ºincrease from ¡to ¡, with an overall increase of ¡ £¨7£©Ôö¼ÓÁË10£¥£ºincrease by (10%) 4£®±¶Êý±È½Ï £¨1£©Ôö¼Ó»ò¼õÉÙ3±¶£ºincrease by 3 fold (times). a 3-fold increase £¨2£©A ÊÇ BµÄ3±¶£ºA is 3 fold (times) as¡as B. A is 3 fold (times) B 5£®½á¹ûµÄͳ¼ÆÑ§ÒâÒå £¨1£©Ã÷ÏÔ²»Í¬£¨significant difference£© £¨2£©ºÜÃ÷ÏÔ²»Í¬£¨very/highly significant difference£© £¨3£©Çø±ð²»Ã÷ÏÔ£¨ insignificant difference£© £¨4£©ÎÞÇø±ð£¨ nonsignificant difference/no difference£© 6£®Í³¼ÆÑ§ÒâÒå³£ÓþäÐÍ £¨1£©There was/is significant difference in¡between A and B £¨2£©The difference in ¡between A and B was/is significant £¨3£©A was/is significant difference from B in ¡ £¨4£©No significant difference was found / observed / noted in ¡between A and B ¡°in¡± ±íÊ¾Çø·ÖµÄÐÔÖÊ»òÄÚÈÝ ¾ÙÀý£º £¨1£©There were no significant difference between treatment groups in symptoms and lung function (P>0.05). £¨2£©Significant difference were not noted in the level of HDL cholesterol, and LDL peak particle diameter before and after treatment. ½áÂÛ²¿·Ö ÊÇ×÷Õß·¢±í¹ÛµãºÍ¼û½â£¬¸ø¶ÁÕߵľ«Ë貿·Ö 1£®¹éÄÉÐÔ˵Ã÷Ñо¿½á¹û»ò·¢ÏÖ 2£®½áÂÛÐÔ˵Ã÷½á¹ûµÄ¿ÉÄÜÔÒò¡¢»úÀí»òÒâÒå 3£®Ç°Õ°ÐÔ˵Ã÷δ½â¾öµÄÎÊÌâ Ò»¡¢½áÂÛ²¿·Öʱ̬ 1£®¹ýȥʱ £¨1£©Éæ¼°±¾Ñо¿µÄÄÚÈÝ £¨2£©Éæ¼°ËûÈËÑо¿¹ý³ÌµÄÄÚÈÝ £¨3£©×÷ÕßÈÏΪֻÊÊÓÃÓÚ±¾Ñо¿»·¾³ºÍÌõ¼þµÄ½áÂÛ 2£®ÏÖÔÚʱ £¨1£©Ö¸Ê¾ÐÔ˵Ã÷ £¨2£©ÆÕ±é½ÓÊܵÄ˼Ïë¡¢ÀíÂÛ»ò½áÂÛ £¨3£©×÷ÕßÈÏΪ±¾Ñо¿½áÂÛ¾ßÓÐÆÕ±éÒâÒå £¨4£©Ç°Õ°ÐÔ˵Ã÷ ¾ÙÀý£ºOur findings indicate that hepatitis C is a progressive disease [ָʾÐÔ˵Ã÷-ÏÖÔÚʱ]£¬but only a few died during the average 20.4 years after the initiation of injection drug use [±¾ÊÔÑé¹ý³ÌÖз¢ÉúµÄÊÂ-¹ýȥʱ£Ý. Antiviral treatment to eradicate the virus and halt the progression of diseases is indicated in this group of patients [×÷ÕßÈÏΪ¾ßÓÐÆÕ±éÒâÒåµÄ½áÂÛ-ÏÖÔÚʱ]. ¶þ¡¢ ½áÂÛ²¿·Ö³£ÓþäÐÍ 1£®½á¹ûÌáʾ¡£ºThese results suggest that¡ ¾ÙÀý£ºThese data confirm the presence of at least two major HCV genotypes in Nigeria. 2£®½á¹ûÖ§³Ö»ò·´¶ÔijÖֹ۵㣺These results support the idea that¡£»These results fail to support the idea that¡ ¾ÙÀý£ºThese results do not support the idea that treatment to lower cholesterol concentration cause mood disturbance. 3£®±íʾ¹ÛµãµÄÈ·¶¨»ò²»È·¶¨ÐÔ£ºThere is no evidence that¡£»It is likely/unlikely that ¡ ¾ÙÀý£ºThere is no evidence that NIDDM produce any change in bone metabolism or mass. 4£®¾ßÓСÒâÒ壺Be of great (some/little/no) clinical significance in¡to ¡ ¾ÙÀý£ºThe detection of p53 gene is of great clinical significance in tumor diagnosis. 5£®Ç°Õ°ÐÔ˵Ã÷£º¡remain to be further studied£»It is remains to be proved that ¡ ¾ÙÀý£ºHowever, the relation of insulin resistance to hypertension remains to be further studied. 6£®²åÈëÓThis is the first case of pancreas divisum. ¾ÙÀý£ºThis is the first case, to our knowledge, of pancreas divisum. С½á ÖÐÎÄÊǹؼü ·ûºÏÓ¢Óïϰ¹ß ²»Óüòµ¥¾ä ×¢Òâ´ÊÓïµÄÓ÷¨ ×¢Òâʱ̬ |
» ²ÂÄãϲ»¶
Çó¹ú¿¼Ë°Îñ»ú¹ØÕп¼ÃæÊÔ¸¨µ¼
ÒѾÓÐ0È˻ظ´
΢ÉúÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ117È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

2Â¥2006-04-29 13:31:28
0.5
| 8´í |
3Â¥2006-04-29 15:29:33
xiaoshitou
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 161
- Ìû×Ó: 149
- ÔÚÏß: 38.6Сʱ
- ³æºÅ: 153190
- ×¢²á: 2006-01-02
- ÐÔ±ð: GG
- רҵ: Ö×ÁöÉúÎïÖÎÁÆ
4Â¥2006-05-04 00:51:41
|
5Â¥2006-05-04 09:50:45
6Â¥2006-05-14 01:17:39
hb1983
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5040.4
- Ìû×Ó: 1672
- ÔÚÏß: 19.3Сʱ
- ³æºÅ: 183385
- ×¢²á: 2006-02-13
- ÐÔ±ð: GG
- רҵ: Íâ¿Æ
7Â¥2006-05-15 11:28:46
0.5
|
8Â¥2006-06-24 15:25:09
9Â¥2006-06-24 16:31:53
Dengren
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 411.6
- Ìû×Ó: 204
- ÔÚÏß: 53·ÖÖÓ
- ³æºÅ: 152952
- ×¢²á: 2006-01-02
- ÐÔ±ð: MM
- רҵ: Ô¤·ÀҽѧÆäËû¿ÆÑ§ÎÊÌâ
10Â¥2006-06-24 19:16:14














»Ø¸´´ËÂ¥